Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3

Cancer Research

Volumn 64, Issue 10, 2004, Pages 3395-3405

  Schaefer, Karl Ludwig ^a   Brachwitz, Kristin ^a   Wai, Daniel H ^b   Braun, Yvonne ^a   Diallo, Raihanatou ^a   Korsching, Eberhard ^b   Eisenacher, Martin ^b   Voss, Reinhard ^c   Van Valen, Frans ^c   Baer, Claudia ^d   Selle, Barbara ^d   Spahn, Laura ^e   Liao, Shuen Kuei ^f   Lee, Kevin A W ^g   Hogendoorn, Pancras C W ^h   Reifenberger, Guido ^a   Gabbert, Helmut E ^a   Poremba, Christopher ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^f CHANG GUNG UNIVERSITY   (Taiwan)

^g HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; CYCLIC AMP; DACARBAZINE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GENE PRODUCT; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PROTEIN S 100; TAMOXIFEN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CHROMOSOME TRANSLOCATION; CLEAR CELL SARCOMA; CLEAR CELL SARCOMA OF SOFT TISSUE; CONTROLLED STUDY; DNA MICROARRAY; ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOGUE 3; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MARKER GENE; MUSCULOSKELETAL SYSTEM; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOFT TISSUE; UNINDEXED SEQUENCE; UPREGULATION;

BLOTTING, NORTHERN; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 22; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; RECEPTOR, ERBB-3; RNA-BINDING PROTEIN EWS; SARCOMA, CLEAR CELL; SARCOMA, EWING'S; SOFT TISSUE NEOPLASMS; TRANSLOCATION, GENETIC; UP-REGULATION;

EID: 2442695564     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0809     Document Type: Article

References (52)

1. Degryse HR. Lesions of uncertain origin. In: AM De Schepper, PM Parizel, F Ramon, L De Beuckeleer, and JE Vandevenne, editors. Imaging of Soft Tissue Tumors. Berlin: Springer; 1997. p. 325-44
2. Kransdorf MJ, Murphey MD. Neurogenic tumors. In: MJ Kransdorf and MD Murphey, editors. Imaging of Soft Tissue Tumors. Philadelphia: W. B. Saunders, 1997. p. 235-73.
3. Sciot R, Speleman F. Clear cell sarcoma of soft tissue. In: CD Fletcher, KK Unni, and F Mertens, editors. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002. pp. 211-2.
4. Chung EB, Enzinger FM. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 1983;7:405-13.
5. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993;4:341-5.
6. Lee KA, Masson N. Transcriptional regulation by CREB and its relatives. Biochim Biophys Acta 1993;1174:221-33.
7. Li KK, Lee KA. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription. Oncogene 1998;16:1325-31.
8. Brown AD, Lopez-Terrada D, Denny C, Lee KA. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene. Oncogene 1995;10:1749-56.
9. Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN, Reddy ES. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene 1996;12:159-67.
10. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. St. Louis, London, Philadelphia, Sydney, Toronto: Mosby, 2001.
11. Graadt van Roggen JF, Mooi WJ, Hogendoorn PC. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol 1998;186:3-7.
12. Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, Baelde JJ, Hogendoorn PC. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 2001;84:535-8.
13. Deenik W, Mooi WJ, Rutgers EJ, Peterse JL, Hart AA, Kroon BB. Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer 1999;86:969-75.
14. Finley JW, Hanypsiak B, McGrath B, Kraybill W, Gibbs JF. Clear cell sarcoma: the Roswell Park experience. J Surg Oncol 2001;77:16-20.
15. Ferrari A, Casanova M, Bisogno G, et al. Clear cell sarcoma of tendons and aponeuroses in pediatric patients: a report from the Italian and German Soft Tissue Sarcoma Cooperative Group. Cancer 2002;94:3269-76.
16. Gray JW, Collins C. Genome changes and gene expression in human solid tumors. Carcinogenesis 2000;21:443-52.
17. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000;405:827-36.
18. Van Valen F, Hanenberg H, Jurgens H. Expression of functional very late antigen-alpha 1, -alpha 2, -alpha 3 and -alpha 6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumour cells and modulation by interferon-gamma and tumour necrosis factor-alpha. Eur J Cancer 1994;30A:2119-25.
19. Schaefer KL, Wai DH, Poremba C, et al. Characterization of the malignant melanoma of soft-parts cell line GG- 62 by expression analysis using DNA microarrays. Virchows Arch 2002;440:476-84.
20. Wai DH, Schaefer KL, Schramm A, et al. Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. Int J Oncol 2002;20:441-51.
21. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002;30:e15.
22. Long AD, Mangalam HJ, Chan BY, Tolleri L, Hatfield GW, Baldi P. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12. J Biol Chem 2001;276:19937-44.
23. Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics 2001;17:509-19.
24. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998;95:14863-8.
25. Poremba C, Scheel C, Hero B, et al. Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues. J Clin Oncol 2000;18:2582-92.
26. Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000;24:227-35.
27. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
28. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-9.
29. Khan J, Wei JS, Ringner M, et al. T1 - Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med 2001;7:673-9.
30. Panagopoulos I, Mertens F, Debiec-Rychter M, et al. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer 2002;99:560-7.
31. Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 1983;71:741-7.
32. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7.
33. Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE. Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol 2001;14:6-9.
34. Segal NH, Pavlidis P, Noble WS, et al. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol 2003;21:1775-81.
35. Li KK, Goodall J, Goding CR, et al. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma. Br J Cancer 2003;89:1072-8.
36. Sassone-Corsi P. Transcription factors responsive to cAMP. Annu Rev Cell Dev Biol 1995;11:355-77.
37. Busca R, Ballotti R. Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment Cell Res 2000;13:60-9.
38. Walker G, Hayward N. No evidence of a role for activating CDK2 mutations in melanoma. Melanoma Res 2001;11:343-8.
39. Bodey B, Kaiser HE, Goldfarb RH. Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy. Anticancer Res 1996;16:517-31.
40. Yarden Y. The EGFR family and its ligands in human cancer, signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001;37 Suppl 4:S3-8.
41. Kreitman RJ. Immunotoxins in cancer therapy. Curr Opin Immunol 1999;11:570-8.
42. Lee H, Akita RW, Sliwkowski MX, Maihle NJ. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4. Cancer Res 2001;61:4467-73.
43. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991;67:1886-93.
44. Dockhorn-Dworniczak B, Schafer KL, Dantcheva R, et al. Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours. Virchows Arch 1994;425:107-12.
45. Van Valen F, Jurgens H, Winkelmann W, Keck E. Beta-adrenergic agonist- and prostaglandin-mediated regulation of cAMP levels in Ewing's sarcoma cells in culture. Biochem Biophys Res Commun 1987;146:685-91.
46. Vormoor J, Baersch G, Decker S, et al. Establishment of an in vivo model for pediatric Ewing tumors by transplantation into NOD/scid mice. Pediatr Res 2001;49:332-41.
47. Whang-Peng J, Triche TJ, Knutsen T, Miser J, Douglass EC, Israel MA. Chromosome translocation in peripheral neuroepithelioma. N Engl J Med 1984;311:584-5.
48. Van Valen F, Winkelmann W, Jurgens H. Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells. J Cancer Res Clin Oncol 1992;118:269-75.
49. Hiraga H, Nojima T, Abe S, et al. Establishment of a new continuous clear cell sarcoma cell line. Morphological and cytogenetic characterization and detection of chimaeric EWS/ATF-1 transcripts. Virchows Arch 1997;431:45-51.
50. Epstein AL, Martin AO, Kempson R. Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma. Cancer Res 1984;44:1265-74.
51. Van Roy N, Forus A, Myklebost O, Cheng NC, Versteeg R, Speleman F. Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP. Cancer Genet Cytogenet 1995;82:151-4.
52. Scheel C, Schaefer KL, Jauch A, et al. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 2001;20:3835-44.